viernes, 4 de octubre de 2019

Leukemia Cure? - Ivanhoe Broadcast News, Inc.

Leukemia Cure? - Ivanhoe Broadcast News, Inc.

Marketing


DENVER, Colo. (Ivanhoe Newswire) — Acute myeloid leukemia, also known as AML is an aggressive cancer that attacks the bone marrow. Around 30,000 people in the US are diagnosed with it each year. 




ORLANDO, Fla. (Ivanhoe Newswire) – Fruits, veggies, salads and even trail mix are a few of the foods that people eat in order to add a little flavor into their diet. 




PHILADELPHIA, Pa. (Ivanhoe Newswire) — More than 50 million people worldwide have epilepsy. For some, medication controls the onset of seizures.  Others need major surgery, and for some, laser ablation is the solution, but there have been no guidelines for doctors to determine how much ablation is just enough to be effective.




ST LOUIS, Mo. (Ivanhoe Newswire) — Every 11 seconds, an older adult is treated in the emergency room for a fall, and every 19 minutes, an older adult dies from one. Doctors are trying to improve those statistics. They’re testing weight-lifting and testosterone gel supplements to give women who break a hip a better shot at a full recovery




ORLANDO, Fla. (Ivanhoe Newswire) – If the sun is out, then the grill is coming out too. Charcoal, electric or gas does not matter, just get the fire started. 








Doctor's In-depth Interview of the week



3D Printing Live Liver Donation: Mom and Son Make History

Manuel Rodriguez-Davalos, MD, Dir, Living Liver Donor Transplant Program
Intermountain Healthcare Transplant Services, Salt Lake City, Utah



Quote of the week:



“If you wish to persuade me, you must think my thoughts, feel my feelings, and speak my words." 

— Marcus Tullius Cicero










If you know of an innovative medical treatment, send us the name of the treatment,  name of the doctor and city. We may be able to cover it in one of our series: newsalert@ivanhoe.com

Website Informationwebdoctor@ivanhoe.com

Content Licensing: jcherry@ivanhoe.com

No hay comentarios:

Publicar un comentario